The assessment of compliance of the inpatient stage pharmacotherapy when treating rheumatoid arthritis with provisions of industry standards
DOI:
https://doi.org/10.24959/cphj.16.1389Keywords:
rheumatoid arthritis, inpatient treatment stage, frequency analysis, gastroprotective drug preventionAbstract
The ongoing monitoring of the inpatient stage of treatment is the necessary condition for improving the quality of pharmacotherapy of such costly diseases as rheumatoid arthritis (RA) and optimizing the costs for its implementation. According to the data of 100 case histories of patients with RA the use of glucocorticoids (GCs), non-steroidal anti-inflammatory drugs (NSAIDs) and gastroprotective drug prevention of complications associated with their use at the inpatient stage of treatment has been analyzed, and compliance of prescriptions with the provisions of the updated national unified clinical protocol of 2014 (UCPMC RA), as well as the recommendations of the European League Against Rheumatism (EULAR) in taking GCs and NSAIDs for rheumatoid diseases has been identified. It was formulated that GCs for systemic use and NSAIDs were prescribed according to the regimens specified in UCPMC RA and in compliance with the algorithm of the rational choice of NSAIDs for RA. It was determined that for the levels of prescriptions of GCs and NSAIDs set the gastroprotective drug prevention of complications associated with their use in the rheumatology department was carried out properly and according to the recommendations of UCPMC RA and EULAR. A high level of compliance by practitioners of a healthcare institution with the provisions of the current UCPMC RA has been determined, and it will allow both preventing in advance possible undesired effects of using GCs and NSAIDs and reducing the costs of their correction.
References
Каратеев Д.Е. // Лечащий врач. – 2002. – №7. [Електронний ресурс] Режим доступу: http:// www.lvrach.ru /2007/02 /4534789
Каратеев А.Е., Насонов Е.Л., Яхно Н.Н. и др. // Современная ревматол. – 2015. – №1. – С. 4-24.
Морозов А.М., Яковлєва Л.В., Бездітко Н.В. та ін. Методичні рекомендації з оцінки клінічної та економічної доцільності використання лікарських засобів у лікувально-профілактичному закладі (супровід формулярної системи). – Х.: НФаУ, 2012. – 59 с.
Нейко Є.М., Яцишин Р.І., Штефюк О.В. // Укр. ревматол. журн. – 2009. – №2 (36). – С. 35-39.
Уніфікований клінічний протокол первинної, вторинної (спеціалізованої), третинної (високоспеціалізованої) медичної допомоги та медичної реабілітації. Ревматоїдний артрит / Під ред. М.К.Хобзей, О.Б.Яременко, О.П.Борткевич та ін. / МОЗ України, ДП «Державний експертний центр МОЗ України». – К., 2014. –42 с.
Hoes J.N., Jacobs J.W.G., Boers M. et al. // Укр. ревматол. журн. – 2008. – №3 (33). – С. 4-13.
Huscher D., Mittendorf T., von Hinüber U. // Ann. Rheumatic Dis. – 2015. – Vol. 74. – P. 738-745.
Raciborski F., Kłak A., Kwiatkowska B. // Reumatol. – 2015. – Vol. 53 (5). – P. 268-275.
Van der Goes M.C., Jacobs J.W., Bijlsma J.W. // Arthritis Res. & Therapy. – 2014. – Vol. 16 (Suppl 2). – S2 Режим доступу: http://arthritis-research.com/content/16/S2/S2
Downloads
Published
Issue
Section
License
Copyright (c) 2016 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
